Similarly, NEK1 T141A overexpressing LNCaP and xenograft tumor remain sensitive to ADT and do not transition to AI growth, which confirms the persistence of TLK1>NEK1 signaling in PCa drug resistance to ADT[30]. The gene discussed is TLK1; the disease is neoplasm.